cardiomyopathy
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with known/suspected LV hypertrophy (Hypertensive Heart Disease, Hypertrophic Cardiomyopathy, Amyloidosis)
Exclusion criteria
Exclusion criteria: Acute coronary syndrome, unstable angina, malignant arrhythmia, severe left ventricular dysfunction, aortic valve stenosis Old myocardial infarction Atrial fibrillation Greater than first degree atrioventricular block, and sick sinus syndrome Percutaneous coronary intervention within 6 months Coronary artery bypass grafting Patient with pacemaker and implantable cardioverter defibrillator Patient with claustrophobia 30% and more than coronary artery stenosis on coronary CT angiography (CTA) Known allergic reaction to contrast media Known history of hyperthyroidism and bronchial asthma Chronic kidney disease Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prognostic value of cardiac CT (CT strain, delayed enhancement CT): total mortality, cardiac death, acute myocardial infarction, admission with cardiac decompensation | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison LV CT-strain with magnetic resonance imaging and echocardiogram (strain, morphological features, cardiac function, fibrosis (delayed enhanced CT) Feasibility of another parameters such as strain rate and minimum principal strain Feasibility of LV CT-strain analysis for systolic and diastolic dysfunction Differentiation of hypertrophic heart using CT strain and strain curve Comparison of delayed enhanced CT and LGE MRI Differentiation of cardiac hypertrophy severity using delayed enhanced CT or CT strain | — |
Countries
Japan
Contacts
Ehime University Hospital School of Medicine Radiology